Showing results (351-360 of 498) with videos related to
Sort By:
Pageof 50
Blood Research|July 5, 2013
Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party RegistryHyeon Gyu Yi, Jin Seok Kim, Cheolwon Suh, et al.Annals of Hematology|June 21, 2014
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II studySeok Jin Kim, Deok-Hwan Yang, Jin Seok Kim, et al.Japanese Journal of Clinical Oncology|April 23, 2005
Phase II study of irinotecan, 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancerSang Hoon Ji, Young Suk Park, Jeeyun Lee, et al.Leukemia & Lymphoma|January 19, 2008
Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphomaByeong-Bae Park, Jin Seok Kim, Young-Yuel Lee, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remissionSe-Hoon Lee, Mark H Lee, Je-Hwan Lee, et al.Japanese Journal of Clinical Oncology|October 7, 2004
Primary pulmonary non-Hodgkin's lymphomaJung Han Kim, Se-Hoon Lee, Jinny Park, et al.Annals of Hematology|October 11, 2015
Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosisSung Hee Lim, Silvia Park, Jun Ho Jang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma studySeok Jin Kim, Kihyun Kim, Byung Soo Kim, et al.Haematologica|June 24, 2021
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 studyAndrew M Evens, Joseph M Connors, Anas Younes, et al.Nature Genetics|March 4, 2014
A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphomaHae Yong Yoo, Min Kyung Sung, Seung Ho Lee, et al.Pageof 50